Standout Papers

Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Frac... 2020 2026 2022 2024176
  1. Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction (2020)
    Paul W. Armstrong, Carolyn S.P. Lam et al. JAMA

Immediate Impact

58 standout
Sub-graph 1 of 20

Citing Papers

Indole-3-Propionic Acid Protects Against Heart Failure With Preserved Ejection Fraction
2024 Standout
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
2024 Standout
4 intermediate papers

Works of Luke Bamber being referenced

Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction
2020 Standout
Patient-Reported Outcomes in the Soluble Guanylate Cyclase Stimulator in Heart Failure Patients with Preserved Ejection Fraction (SOCRATES-PRESERVED) Study
2017

Author Peers

Author Last Decade Papers Cites
Luke Bamber 830 639 141 178 27 1.1k
Marcel A. van de Ree 477 457 55 486 38 1.2k
Christine G. Kohn 325 289 107 149 46 928
A G Fennerty 391 497 31 160 29 1.1k
Florence Le Maulf 635 615 51 223 18 1.2k
Paul Nguyen 718 566 26 256 33 1.1k
John Simes 303 283 102 271 28 1.1k
Paul R. Daniels 639 613 24 410 43 1.1k
Charles E. Mahan 687 793 56 199 35 996
Ma Luisa Suárez‐Gea 586 500 39 133 26 908
Noémie Kraaijpoel 367 632 25 277 36 977

All Works

Loading papers...

Rankless by CCL
2026